In February, 2023 Imara merged with Enliven therapeutics (ELVN), with the resulting firm retaining Enliven’s name and development pipeline. Enliven is a clinical-stage precision oncology company focused on the discovery and development of next-generation small molecule kinase inhibitors to help patients with cancer live not only longer, but better.
Company Details
- Employees
- 11
- Founded
- -
- Address
- Boston, Ma, Us
- Phone
- 617 231-6021
- in****@****atx.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- imaratx.com
- HQ
- Boston, MA
Imara Inc. Questions
Imara Inc.'s helpline number is 617 231-6021
Imara Inc.'s website is imaratx.com
Imara Inc.'s LinkedIn profile is https://www.linkedin.com/company/imarainc
Imara Inc. has
11 employees.
View email and phone details for 11
employees at Imara Inc..
Imara Inc.'s industry is
Biotechnology Research
Imara Inc.'s top competitors are
Rgenta Therapeutics Inc.,
Peca Labs,
Beam Therapeutics,
Ingmar Medical,
Edgewise Therapeutics,
Aquinnah Pharmaceuticals,
Enliven Therapeutics,
Mediar Therapeutics,
Keros Therapeutics,
Lucy Therapeutics.
Imara Inc.'s support email address is info@imaratx.com
Imara Inc.'s categories are Biotechnology Research
Imara Inc.'s founding year is 2016
